Scientists have developed a simple test that can identify 18 early-stage cancers that experts say could represent a medical “gamechanger.”
Cancer accounts for one in every six deaths worldwide, but early detection can significantly improve outcomes.
Existing screening tests have drawbacks, including invasiveness, cost and low levels of accuracy for early stage disease.
Photo: EPA-EFE
Now US researchers have designed a test that analyses proteins in the blood and can pick up 18 early stage cancers, representing all main organs in the human body.
Specific blood proteins could already be used for early detection and monitoring, but until now tests have lacked sensitivity — accuracy of picking up those with cancer — and specificity — accuracy of excluding those without cancer, the researchers said.
The team, from the US biotech firm Novelna, said their test outperformed others relying on tumor DNA in the blood, and had “a sensitivity much greater” than the Galleri test being trialed on the NHS in the UK.
Photo: AFP
By looking at proteins in blood plasma, the experts were able to differentiate cancer samples from normal ones, and even distinguish between different types of cancers “with high accuracy,” they said. The research also found evidence that cancer protein signals were likely to be sex-specific.
Writing in the journal BMJ Oncology, the team said: “This finding is the foundation for a multi-cancer screening test for the early detection of 18 solid tumors that cover all major human organs of origin for such cancers at the earliest stage of their development with high accuracy.”
They added: “This could re-shape screening guidelines, making this plasma test a standard part of routine check-ups.”
Photo: AP
“These findings pave the way for a cost-effective, highly accurate, multi-cancer screening test that can be implemented on a population-wide scale.”
Blood plasma samples were collected from 440 people diagnosed with 18 different types of cancer, and from 44 healthy blood donors.
The team then identified proteins which showed early stage cancers and where they originated in the body “with high accuracy.”
The team wrote: “At stage I (the earliest cancer stage) and at the specificity of 99 percent, our panels were able to identify 93 percent of cancers among males and 84 percent of cancers among females.
“Our sex-specific localization panels consisted of 150 proteins and were able to identify the tissue of origin of most cancers in more than 80 percent of cases.”
Analysis of the plasma protein also showed almost all of them were present at very low levels. This shows the importance of low-level proteins to pick up pre-cancerous and early stage disease before a tumor has had time to cause substantial damage, the team said.
But the team said their relatively small sample size meant further studies were needed in bigger groups of people.
Mangesh Thorat, of the Centre for Cancer Prevention at the Wolfson Institute of Preventive Medicine, who was not involved with the study, said there remained questions about the test and more studies were needed.
“However, the interesting aspects of this assay are a much higher sensitivity for stage I cancers than other similar assays in development and gender-specific performance differences which are biologically and clinically relevant,” he said.
“If the assay performance in future, well-designed sequential studies is anywhere close to what this preliminary study suggests, then it could really be a gamechanger.”
Prof Paul Pharoah, a cancer epidemiology expert at Cedars-Sinai Medical Center, who was also not involved in the study, welcomed the findings but urged caution.
“Simple blood tests that can detect many different cancers in the early stages (test is sensitive) and do not generate false positives (test is specific) are a holy grail for early detection,” he said.
“This paper reports on the initial results of the development of one such test. While the results show some promise, it is far too soon to be confident that this test will turn out to be useful for early cancer detection.”
If one asks Taiwanese why house prices are so high or why the nation is so built up or why certain policies cannot be carried out, one common answer is that “Taiwan is too small.” This is actually true, though not in the way people think. The National Property Administration (NPA), responsible for tracking and managing the government’s real estate assets, maintains statistics on how much land the government owns. As of the end of last year, land for official use constituted 293,655 hectares, for public use 1,732,513 hectares, for non-public use 216,972 hectares and for state enterprises 34 hectares, yielding
The small platform at Duoliang Train Station in Taitung County’s Taimali Township (太麻里) served villagers from 1992 to 2006, but was eventually shut down due to lack of use. Just 10 years later, the abandoned train station had become widely known as the most beautiful station in Taiwan, and visitors were so frequent that the village had to start restricting traffic. Nowadays, Duoliang Village (多良) is known as a bit of a tourist trap, with a mandatory, albeit modest, admission fee of NT$10 giving access to a crowded lane of vendors with a mediocre view of the ocean and the trains
The March/April volume of Foreign Affairs, long a purveyor of pro-China pablum, offered up another irksome Beijing-speak on the issues and solutions for the problems vexing the People’s Republic of China (PRC) and the US: “America and China at the Edge of Ruin: A Last Chance to Step Back From the Brink” rang the provocative title, by David M. Lampton and Wang Jisi (王緝思). If one ever wants to describe what went wrong with US-PRC relations, the career of Wang Jisi is a good place to start. Wang has extensive experience in the US and the West. He was a visiting
One of the challenges with the sheer availability of food in today’s world is that lots of us end up spending many of our waking hours eating. Whether it’s full meals, snacks or desserts, scientists have found that it’s not uncommon for us to be mindlessly grazing at some point during all of our 16 or so waking hours. The problem? As soon as this food hits the bloodstream in the form of glucose, it initiates the release of the hormone insulin. This in turn activates a switch present in every one of our cells, which is responsible for driving cell